ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan · Delayed Price · Currency is TWD 71.20
+0.40 (0.56%)
May 8, 2026, 1:53 PM CST
ACRO Biomedical Market Cap
ACRO Biomedical has a market cap or net worth of 4.35 billion as of May 8, 2026. Its market cap has increased by 98.60% in one year.
Market Cap
4.35B
Enterprise Value
3.38B
Revenue
38.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
71.20
Market Cap Chart
Since July 27, 2021, ACRO Biomedical's market cap has increased from 990.62M to 4.35B, an increase of 338.77%. That is a compound annual growth rate of 36.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 4.35B | 7.58% |
| Dec 31, 2025 | 4.04B | 158.32% |
| Dec 31, 2024 | 1.56B | -35.07% |
| Dec 29, 2023 | 2.41B | 135.16% |
| Dec 30, 2022 | 1.02B | 9.09% |
| Dec 30, 2021 | 938.97M | -5.21% |
| Jul 27, 2021 | 990.62M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UnicoCell Biomed | 5.30B |
| Steminent Biotherapeutics | 5.00B |
| Medigen Biotechnology | 4.60B |
| Senhwa Biosciences | 4.59B |
| Pharmosa Biopharm | 4.49B |
| OBI Pharma | 4.48B |
| Formosa Pharmaceuticals | 4.06B |
| Sinew Pharma | 3.90B |